2 research outputs found

    Π‘ΠΎΠ²Ρ€Π΅ΠΌΠ΅Π½Π½ΠΎΠ΅ состояниС ΠΏΡ€ΠΎΠ±Π»Π΅ΠΌΡ‹ систСмной красной Π²ΠΎΠ»Ρ‡Π°Π½ΠΊΠΈ Π² ΠšΠ°Π·Π°Ρ…ΡΡ‚Π°Π½Π΅

    Get PDF
    Objective: to analyze the provision of medical, including rheumatology, care in Kazakhstan, to study the incidence of systemic lupus erythematosus (SLE), and to develop a registry of patients with this condition.Material and methods. The investigators analyzed the guidelines for the organization of medical, including rheumatology, care in the republic and the official statistical materials of the Ministry of Health of the Republic of Kazakhstan in the period 2012 to 2017. Articles were searched to select activity indices, organ damages and to assess the quality of life and treatment programs in order to create a registry of patients with SLE.Results and discussion. The paper presents the basic principles of providing medical, including rheumatology, care in the republic. It gives data on the issues of providing SLE patients with medicines in outpatient and inpatient settings. It also analyzes trends in the incidence of SLE in the population of Kazakhstan in 2012 to 2017. There were 4,448 SLE patients, including 3,986 women; a comparative analysis of indicators demonstrated a 62.8% increase in the incidence of SLE from 2012 to 2017. The purpose and objectives of the registry of patients with SLE were substantiated.Conclusion. An analysis of morbidity rates suggests that SLE remains to be significant in the republic. The incidence of SLE has been noted to increase in the period from 2012 to 2017; there is a female preponderance (89.6%). The application of the SLE registry in clinical practice will be able to improve the diagnosis of the disease in the early stage and to prevent possible complications. ЦСль исслСдования – Π°Π½Π°Π»ΠΈΠ· оказания мСдицинской, Π² Ρ‚ΠΎΠΌ числС рСвматологичСской, ΠΏΠΎΠΌΠΎΡ‰ΠΈ Π² ΠšΠ°Π·Π°Ρ…ΡΡ‚Π°Π½Π΅, ΠΈΠ·ΡƒΡ‡Π΅Π½ΠΈΠ΅ ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ заболСваСмости ΠΈ Ρ€Π°Π·Ρ€Π°Π±ΠΎΡ‚ΠΊΠ° рСгистра ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с систСмной красной Π²ΠΎΠ»Ρ‡Π°Π½ΠΊΠΎΠΉ (Π‘ΠšΠ’).ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π» ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. ΠŸΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»ΡΡ Π°Π½Π°Π»ΠΈΠ· руководящих Π΄ΠΎΠΊΡƒΠΌΠ΅Π½Ρ‚ΠΎΠ² ΠΏΠΎ ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΠΈ мСдицинской, Π² Ρ‚ΠΎΠΌ числС рСвматологичСской, ΠΏΠΎΠΌΠΎΡ‰ΠΈ Π² рСспубликС ΠΈ ΠΎΡ„ΠΈΡ†ΠΈΠ°Π»ΡŒΠ½Ρ‹Ρ… статистичСских ΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»ΠΎΠ² ΠœΠΈΠ½ΠΈΡΡ‚Π΅Ρ€ΡΡ‚Π²Π° здравоохранСния РСспублики ΠšΠ°Π·Π°Ρ…ΡΡ‚Π°Π½ (ΠœΠ— РК) Π·Π° ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ с 2012 ΠΏΠΎ 2017 Π³. Π’Ρ‹ΠΏΠΎΠ»Π½Π΅Π½ поиск статСй для ΠΎΡ‚Π±ΠΎΡ€Π° индСксов активности, поврСТдСния ΠΎΡ€Π³Π°Π½ΠΎΠ², ΠΎΡ†Π΅Π½ΠΊΠΈ качСства ΠΆΠΈΠ·Π½ΠΈ ΠΈ ΠΏΡ€ΠΎΠ³Ρ€Π°ΠΌΠΌΡ‹ Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ с Ρ†Π΅Π»ΡŒΡŽ создания рСгистра ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с Π‘ΠšΠ’.Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ ΠΈ обсуТдСниС. ΠŸΡ€Π΅Π΄ΡΡ‚Π°Π²Π»Π΅Π½Ρ‹ основныС ΠΏΡ€ΠΈΠ½Ρ†ΠΈΠΏΡ‹ оказания мСдицинской, Π² Ρ‚ΠΎΠΌ числС рСвматологичСской, ΠΏΠΎΠΌΠΎΡ‰ΠΈ Π² рСспубликС. ΠŸΡ€ΠΈΠ²Π΅Π΄Π΅Π½Ρ‹ Π΄Π°Π½Π½Ρ‹Π΅ ΠΏΠΎ вопросам обСспСчСния ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с Π‘ΠšΠ’ лСкарствСнными срСдствами Π½Π° Π°ΠΌΠ±ΡƒΠ»Π°Ρ‚ΠΎΡ€Π½ΠΎΠΌ ΠΈ стационарном этапС. ΠŸΡ€ΠΎΠ²Π΅Π΄Π΅Π½ Π°Π½Π°Π»ΠΈΠ· Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠΈ заболСваСмости Π‘ΠšΠ’ насСлСния ΠšΠ°Π·Π°Ρ…ΡΡ‚Π°Π½Π° Π·Π° ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ с 2012 ΠΏΠΎ 2017 Π³. Число ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с Π‘ΠšΠ’ составило 4448 Ρ‡Π΅Π»ΠΎΠ²Π΅ΠΊ (ΠΈΠ· Π½ΠΈΡ… ΠΆΠ΅Π½Ρ‰ΠΈΠ½ – 3986), ΡΡ€Π°Π²Π½ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹ΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ Π·Π° ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ с 2012 ΠΏΠΎ 2017 Π³. продСмонстрировал ΡƒΠ²Π΅Π»ΠΈΡ‡Π΅Π½ΠΈΠ΅ заболСваСмости Π½Π° 62,8%. ΠžΠ±ΠΎΡΠ½ΠΎΠ²Ρ‹Π²Π°ΡŽΡ‚ΡΡ Ρ†Π΅Π»ΡŒ ΠΈ Π·Π°Π΄Π°Ρ‡ΠΈ рСгистра ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с Π‘ΠšΠ’.Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. Анализ ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ заболСваСмости ΡΠ²ΠΈΠ΄Π΅Ρ‚Π΅Π»ΡŒΡΡ‚Π²ΡƒΡŽΡ‚ ΠΎ сохранСнии значимости Π‘ΠšΠ’ Π² рСспубликС. ΠžΡ‚ΠΌΠ΅Ρ‡Π΅Π½Ρ‹ прирост заболСваСмости Π‘ΠšΠ’ Π² ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ с 2012 ΠΏΠΎ 2017 Π³., ΠΏΡ€Π΅ΠΎΠ±Π»Π°Π΄Π°Π½ΠΈΠ΅ Π»ΠΈΡ† ТСнского ΠΏΠΎΠ»Π° (89,6%). ИспользованиС рСгистра ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с Π‘ΠšΠ’ Π² клиничСской ΠΏΡ€Π°ΠΊΡ‚ΠΈΠΊΠ΅ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΡ‚ ΡƒΠ»ΡƒΡ‡ΡˆΠΈΡ‚ΡŒ диагностику заболСвания Π½Π° Ρ€Π°Π½Π½Π΅ΠΌ этапС ΠΈ ΠΏΡ€Π΅Π΄ΠΎΡ‚Π²Ρ€Π°Ρ‚ΠΈΡ‚ΡŒ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½Ρ‹Π΅ ослоТнСния.

    The current status of the problem with systemic lupus erythematosus in Kazakhstan

    Get PDF
    Objective: to analyze the provision of medical, including rheumatology, care in Kazakhstan, to study the incidence of systemic lupus erythematosus (SLE), and to develop a registry of patients with this condition.Material and methods. The investigators analyzed the guidelines for the organization of medical, including rheumatology, care in the republic and the official statistical materials of the Ministry of Health of the Republic of Kazakhstan in the period 2012 to 2017. Articles were searched to select activity indices, organ damages and to assess the quality of life and treatment programs in order to create a registry of patients with SLE.Results and discussion. The paper presents the basic principles of providing medical, including rheumatology, care in the republic. It gives data on the issues of providing SLE patients with medicines in outpatient and inpatient settings. It also analyzes trends in the incidence of SLE in the population of Kazakhstan in 2012 to 2017. There were 4,448 SLE patients, including 3,986 women; a comparative analysis of indicators demonstrated a 62.8% increase in the incidence of SLE from 2012 to 2017. The purpose and objectives of the registry of patients with SLE were substantiated.Conclusion. An analysis of morbidity rates suggests that SLE remains to be significant in the republic. The incidence of SLE has been noted to increase in the period from 2012 to 2017; there is a female preponderance (89.6%). The application of the SLE registry in clinical practice will be able to improve the diagnosis of the disease in the early stage and to prevent possible complications
    corecore